

English
-
Dealing with Dengue
-
-
Integrated Dengue Management
Takeda2 minutes -
Dengue without warning signs: Outpatient management in the public and private setting
ADS22 minutes -
Clinical Management of Dengue with Warning Signs
ADS23 minutes -
The Current Dengue Therapeutics Guideline and How to Deliver Effective Treatment
ADS12 minutes -
Best Practice in Dengue in patient management
ADS18 minutes -
Mass Vaccination During the 2024 Dengue Outbreak in Brazil
ADS27 minutes -
Ideal Dengue Vaccine Characteristics
Medscape -
Dengue Immunization: Special Populations
Medscape -
Dengue Prevention: Integrating Vaccination Into Comprehensive Control Strategies Across Populations
Medscape -
Dengue: Vaccinating Travelers to Endemic Regions
Medscape -
Case presentations in severe dengue: contemporary approaches to clinical management
Medscape45 minutes -
Clinical diagnosis and management of dengue
PAHO -
Dengue Clinical Case Management
CDC -
Dengue: diagnosis and treatment updates
ISID62 minutes -
Dengue diagnosis: unique challenges in a time of a pandemic
Medscape15 minutes -
Management of cases
Takeda1 minutes -
Zika and dengue but not chikungunya are associated with Guillain–Barré syndrome in Mexico: A case-control study
Takeda2 minutes -
Experience of a tertiary hospital in Singapore managing a dual outbreak of COVID and dengue
Takeda2 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
This website is intended for informational purposes only and is not a substitute for healthcare professional’s clinical knowledge or professional judgment.
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023